Electrostatic interactions of androgens and progesterone derivatives with rainbow trout estrogen receptor.
In primary cultures of immature male rainbow trout (rt) hepatocytes, vitellogenin (Vg) gene expression is regulated by E(2) via the estrogen receptor (ER). However, steroids other than estrogens can also stimulate Vg gene expression. These steroids are hardly converted into E(2) during incubation and their stimulatory activity is completely inhibited by tamoxifen implying rtER involvement. These steroids have no or a slightly positive charge on the Connolly surface. In contrast, steroids that failed to stimulate Vg gene expression had a strong positive or negative charge around rings C and D due to polarization. The amino acid sequences of the ligand binding domains (LBD) of rtER and human ER alpha have 57.7% homology; only one amino acid differs in the presumed steroid binding site. We modeled the three-dimensional structure of the LBD of rtER using X-ray crystallographic data for hER alpha in order to investigate the fit (structural and electrostatic) between steroid and rtER. Two factors are essential for binding to rtER: (i) hydroxyl or carbonyl groups near C3 and C17 of the steroids (hydrophilic regions) that can form hydrogen bonds with His(489), Arg(359), and Glu(318), (ii) a hydrophobic steroid nucleus that interacts with a hydrophobic region of the rtER LBD through van der Waals forces. If polar functional groups are present, the hydrophobic interaction between steroid and the rtER LBD is considerably weakened.
Laboratory of Physiology, Faculty of Fisheries, Hokkaido University, 3-1-1 Minato, Hakodate Hokkaido 041 8611, Japan. tmori@pop.fish.hokudai.ac.jp
T
T
Mori
S
S
Sumiya
H
H
Yokota
D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D015152:Blotting, Northern; D002478:Cells, Cultured; D002996:Clomiphene / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D018360:Crystallography, X-Ray; D004958:Estradiol / Q000378:metabolism / Q000494:pharmacology; D022781:Hepatocytes / Q000737:chemistry / Q000187:drug effects*; D006801:Humans; D008297:Male; D008958:Models, Molecular; D008969:Molecular Sequence Data; D015394:Molecular Structure; D017686:Oncorhynchus mykiss; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011960:Receptors, Estrogen / Q000737:chemistry* / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D016415:Sequence Alignment; D013629:Tamoxifen / Q000378:metabolism / Q000494:pharmacology*; D014819:Vitellogenins / Q000235:genetics / Q000378:metabolism
D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D014819:Vitellogenins; D013629:Tamoxifen; D002996:Clomiphene; D004958:Estradiol